Abstract
Cerebral syphilitic gumma (CSG) is an extremely rare manifestation of neurosyphilis that often mimics brain tumors, frequently leading to pathological confirmation only after surgical intervention. This study reports three cases of CSG. The first two cases involved older men (62 and 66 years old) presenting with acute neurological deficits; both underwent surgery due to significant midline shifts and were confirmed via postoperative pathology. The third case involved a 37-year-old man with dizziness whose condition was diagnosed through MRI and serology and successfully treated with antibiotics alone. We recommend critical interpretation of preoperative imaging, detailed patient history, and routine syphilis serology to avoid unnecessary surgery and prioritize stabilizing medical treatment.
Introduction
Syphilis, caused by Treponema pallidum, is experiencing a global resurgence. While neurosyphilis is a recognized complication, the "gumma"—a localized, inflammatory granulomatous lesion—is exceptionally rare in the brain. The primary clinical challenge is diagnostic: CSG lacks pathognomonic imaging features and often appears identical to high-grade gliomas, meningiomas, or lymphomas on MRI. Because of social stigma, patients may omit a history of infection, leading clinicians to perform invasive neurosurgery for a condition that could be resolved with penicillin. This paper aims to refine diagnostic criteria to prevent such unnecessary procedures.
Methods and Materials
This study performed a retrospective analysis of three male patients treated at Yi-Ji Shan Hospital in China. The diagnostic approach integrated multi-modal imaging (CT and MRI including T1, T2, FLAIR, DWI, and contrast enhancement) with laboratory testing of blood and cerebrospinal fluid (CSF) for syphilis-specific markers (RPR and TPPA).
For the two surgical cases, histopathological analysis was conducted using Hematoxylin and Eosin (HE) staining and Warthin-Starry staining to identify bacterial presence. Immunohistochemical markers (GFAP, Ki67, and P53) were used to rule out malignancy.
Key Results
Case 1 & 2: Surgical Intervention
Case 1 (62M) presented with speech arrest, and Case 2 (66M) presented with vision loss and headache. MRI for both showed irregular high-signal foci with significant edema and midline shifts. Post-operative pathology confirmed CSG through the presence of plasma cells, lymphocytes, and characteristic "sleeve-like" infiltration around blood vessels. Notably, Warthin-Starry staining did not identify T. pallidum spirochetes, which is typical for gummas as they represent an inflammatory response rather than a high bacterial load site.
Case 3: Medical Management
A 37-year-old male presented with dizziness. MRI indicated abnormal lamellar signals. Positive TPPA and RPR tests led to a diagnosis of CSG without surgery. Following a 14-day course of intravenous penicillin (2.4 million U every 4 hours), a 6-month follow-up MRI showed total absorption of the lesions and complete symptom resolution.
Discussion and Clinical Insights
Diagnostic Clues
While CSG mimics meningiomas, several features can aid differentiation:
- Meningeal Tail Sign: Often present in CSG, but usually accompanied by necrotic centers and more extensive perilesional edema than typical meningiomas.
- The Obtuse Angle: CSG typically intersects with the surrounding meninges at an obtuse angle.
- Serological Screening: Given the diagnostic ambiguity, clinicians should proactively order RPR/TPPA tests for any meningeal-related lesion with significant edema, regardless of the patient's stated history.
Treatment Strategy
Surgery should be reserved for cases where the gumma causes acute intracranial hypertension or life-threatening midline shifts. In stable patients, high-dose penicillin therapy is the preferred first-line treatment, often resulting in complete radiological and clinical recovery.
Conclusion
Cerebral syphilitic gumma remains a diagnostic pitfall. A high index of clinical suspicion, combined with routine serological testing and careful MRI analysis, can differentiate CSG from intracranial tumors. This approach allows for effective antibiotic treatment and spares patients the risks associated with unnecessary neurosurgery.
Summary updated